Bankruptcy filing worries developers of nanoparticle cancer drugs
Wednesday, May 18, 2016 - 06:30
in Mathematics & Economics
Financial woes of leading biotech firm highlight challenges of developing innovative therapies.Nature 533 304 doi: 10.1038/533304a